Breakthrough trial may improve diagnosis and life outcomes for patients with high-risk myeloma Sep 10, 2023
Study uses genomic data to produce high-resolution serial interval estimates for COVID-19 Aug 16, 2023
MaxCyte signs strategic platform license with prime medicine to advance next-generation gene editing therapies for patients Aug 10, 2023